Literature DB >> 35227205

Correction to: Assessing and disclosing test results for 'mild cognitive impairment': the perspective of old age psychiatrists in Scotland.

Stina Saunders1, Craig W Ritchie2,3, Tom C Russ2,4, Graciela Muniz-Terrera2, Richard Milne5,6.   

Abstract

Entities:  

Year:  2022        PMID: 35227205      PMCID: PMC8887141          DOI: 10.1186/s12877-022-02770-9

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


× No keyword cloud information.
Correction to: BMC Geriatr 22, 50 (2022) https://doi.org/10.1186/s12877-021-02693-x After publication of this article [1], the authors reported that in the section “Background”, third paragraph, the first sentence was incorrectly given as “Considering MCI as prodromal MCI, the assessments are in line with clinical investigations for early Alzheimer’s disease dementia,…” and should have read “Considering MCI as prodromal AD, the assessments are in line with clinical investigations for early AD,…”. Moreover, Fig. 1 did not match with the figure legend and axis description. The figure should have appeared as shown below.
Fig. 1

Routine investigations carried out in MCI: [1] Clinical history including functional assessment, [2] Global cognitive assessment (ACE III), [3] Neuroimaging, [4] Referral to neuropsychological assessment [5] Occupational Therapy assessment, [6] C SF testing, [7] PET imaging for any ligand (FDG/Amyloid/DAT)

Routine investigations carried out in MCI: [1] Clinical history including functional assessment, [2] Global cognitive assessment (ACE III), [3] Neuroimaging, [4] Referral to neuropsychological assessment [5] Occupational Therapy assessment, [6] C SF testing, [7] PET imaging for any ligand (FDG/Amyloid/DAT) The original article [1] has been updated.
  1 in total

1.  Assessing and disclosing test results for 'mild cognitive impairment': the perspective of old age psychiatrists in Scotland.

Authors:  Stina Saunders; Craig W Ritchie; Tom C Russ; Graciela Muniz-Terrera; Richard Milne
Journal:  BMC Geriatr       Date:  2022-01-12       Impact factor: 3.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.